Authors
Latest:
Offer Patients Counseling on ADFsPharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.
Latest:
Natural Products on Deck: Keeping Joints in the GameMany patients with osteoarthritis turn to complementary and alternative medicine, either as an adjunct to prescription therapy or to avoid side effects.
Latest:
Parkinson's Disease Psychosis: A Pharmacist's Update of New Treatment OptionsThis Continuing Education activity is supported by an educational grant from Acadia Pharmaceuticals Inc.
Latest:
Opioid-Induced Constipation: Considerations for Formulary Decision MakersThis activity reviews the incidence and impact of opioid-induced constipation (OIC), discusses available treatment options, and what factors should be considered during formulary decisions for OIC.
Latest:
Drivers of Change in Pharmacy Benefit ManagementExecutive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.
Latest:
Ivosidenib for Relapsed/Refractory Acute Myeloid LeukemiaOn July 20, 2018, the FDA approved ivosidenib (Tibsovo) as a treatment option for adult patients with relapsed/refractory acute myeloid leukemia, specifically with a mutation in the IDH1 gene.
Latest:
Addressing HIV with Incarcerated Individuals Requires Understanding of PrEPThe prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.
Latest:
Reflecting on the History of Specialty PharmacyMaking the jump from retail to specialty pharmacy.
Latest:
Geriatric Cancers Present Many Therapeutic ChallengesPharmacists should develop treatment plans with an active interdisciplinary team and patient involvement.
Latest:
Improving Asthma Management with Tools and DevicesThis Continuing Education activity is supported by an educational grant from Philips Respironics, Inc.
Latest:
Current and Future Status of Drug Pricing Reform as the Blueprint Approaches the 1-Year MarkSeveral efforts are underway nearly a year after the Trump administration released its blueprint to lower drug prices in May 2018, but tracking their outcomes depends on what metric is used to define drug prices, according to a session at the Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting, held March 25-28 in San Diego, California.
Latest:
Mental Health First Aid as a Skill Set for Community Pharmacy PersonnelMental illness affects tens of millions of people in the United States each year. However, overall, only about half of those affected receive treatment.
Latest:
Cost-Effectiveness of Live Attenuated Versus Inactivated Influenza Vaccine Among ChildrenVaccination with trivalent live attenuated versus inactivated influenza vaccine in children aged 2 to 17 years is cost saving or cost-effective depending on the severity of the influenza season.
Latest:
Expand Your Pharmacy FootprintWith national brand recognition and expert support, pharmacy franchise owners reach more patients.
Latest:
Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification SystemA controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.
Latest:
Barriers to and Facilitators of Medication AdherenceThis study reports on barriers to and facilitators of medication adherence for asthma and diabetes patients who were both adherent and nonadherent to their medication regimen.
Latest:
Could Preemptive Pharmacogenomic Testing Emerge as an MTM Best Practice?Pharmacists and physicians can now use pharmacogenomic test results to help choose safer and more effective medications for their patients.
Latest:
Zooming Through the Pandemic: NSU Virtual AMCP Student ChapterThere are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Latest:
Brown Bag Consult®: Chronic Lymphocytic LeukemiaA patient with CLL relies on his pharmacy team for support.
Latest:
Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric HospitalAdherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.
Latest:
Advancing Multistate Licensure Is Vital in Telehealth EraBut meeting regulatory requirements may entail a great deal of financial expertise and time.
Latest:
Antimicrobial Stewardship Targets in Community-Acquired PneumoniaAntimicrobial stewardship programs (ASPs) are often tasked with addressing a wide scope of antimicrobial misuse with limited resources.
Latest:
Diabetes Specialized Medication Therapy ManagementThe impact of the community pharmacist on insulin therapy is explored.
Latest:
Enterprise Collaborations Help Meet ChallengesCommunity Health Network of Indianapolis and Walgreens are leveraging each other’s strengths to design and implement programs.
